Commentary: 50 Years of the EORTC – making the difference for the European Oncology Community
28 Aug 2012
Prof Françoise Meunier, Director General, EORTC
In this interview with Mark Lawler, Interlocutor – European Perspectives for The Oncologist, Prof Françoise Meunier, EORTC Director General, recounts some of the successes of the EORTC and identifies key challenges it faces in its pioneering role in the research and treatment of cancer in Europe.
Please also see the accompanying article to this video which appeared in The Oncologist.
Related News
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
